229 related articles for article (PubMed ID: 15517419)
1. Long-term effects of levamisole treatment in childhood nephrotic syndrome.
Sümegi V; Haszon I; Iványi B; Bereczki C; Papp F; Túri S
Pediatr Nephrol; 2004 Dec; 19(12):1354-60. PubMed ID: 15517419
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of higher-dose levamisole in maintaining remission in steroid-dependant nephrotic syndrome.
Abeyagunawardena AS; Karunadasa U; Jayaweera H; Thalgahagoda S; Tennakoon S; Abeyagunawardena S
Pediatr Nephrol; 2017 Aug; 32(8):1363-1367. PubMed ID: 28299461
[TBL] [Abstract][Full Text] [Related]
3. Effect of levamisole in steroid-dependent nephrotic syndrome.
Madani A; Isfahani ST; Rahimzadeh N; Fereshtehnejad SM; Hoseini R; Moghtaderi M; Mohseni P; Ataiee N
Iran J Kidney Dis; 2010 Oct; 4(4):292-6. PubMed ID: 20852369
[TBL] [Abstract][Full Text] [Related]
4. Levamisole therapy in corticosteroid-dependent nephrotic syndrome.
Bagga A; Sharma A; Srivastava RN
Pediatr Nephrol; 1997 Aug; 11(4):415-7. PubMed ID: 9260236
[TBL] [Abstract][Full Text] [Related]
5. Experience with levamisole in frequently relapsing, steroid-dependent nephrotic syndrome.
Al-Saran K; Mirza K; Al-Ghanam G; Abdelkarim M
Pediatr Nephrol; 2006 Feb; 21(2):201-5. PubMed ID: 16222548
[TBL] [Abstract][Full Text] [Related]
6. Levamisole in Frequently-relapsing and Steroid-dependent Nephrotic Syndrome.
Kiruba Samuel EM; Krishnamurthy S; Bhanudeep S; Muske S
Indian Pediatr; 2017 Oct; 54(10):831-834. PubMed ID: 28699616
[TBL] [Abstract][Full Text] [Related]
7. Long-term efficacy and safety of common steroid-sparing agents in idiopathic nephrotic children.
Basu B; Babu BG; Mahapatra TK
Clin Exp Nephrol; 2017 Feb; 21(1):143-151. PubMed ID: 27108294
[TBL] [Abstract][Full Text] [Related]
8. [The treatment with levamisole of frequently recurring steroid-sensitive idiopathic nephrotic syndrome in children].
Kemper MJ; Amon O; Timmermann K; Altrogge H; Müller-Wiefel DE
Dtsch Med Wochenschr; 1998 Feb; 123(9):239-43. PubMed ID: 9524533
[TBL] [Abstract][Full Text] [Related]
9. Levamisole treatment in steroid-sensitive and steroid-resistant nephrotic syndrome.
Tenbrock K; Müller-Berghaus J; Fuchshuber A; Michalk D; Querfeld U
Pediatr Nephrol; 1998 Aug; 12(6):459-62. PubMed ID: 9745868
[TBL] [Abstract][Full Text] [Related]
10. [Multicenter survey of diagnostic and therapeutic status in Chinese childhood patients with steroid-sensitive, relaping/steroid-dependent nephrotic syndrome].
Working Group For National Survey On Status Of Diagnosis And Treatment Of Childhood Renal Diseases
Zhonghua Er Ke Za Zhi; 2014 Mar; 52(3):194-200. PubMed ID: 24824389
[TBL] [Abstract][Full Text] [Related]
11. Levamisole in steroid dependent and frequently relapsing nephrotic syndrome.
Hafeez F; Ahmed TM; Samina U
J Coll Physicians Surg Pak; 2006 Jan; 16(1):35-7. PubMed ID: 16441986
[TBL] [Abstract][Full Text] [Related]
12. Levamisole vs. cyclophosphamide for frequently-relapsing steroid-dependent nephrotic syndrome.
Alsaran K; Grisaru S; Stephens D; Arbus G
Clin Nephrol; 2001 Oct; 56(4):289-94. PubMed ID: 11680658
[TBL] [Abstract][Full Text] [Related]
13. Levamisole in steroid-sensitive nephrotic syndrome children with steroid-dependency and/or frequent relapses.
Fu LS; Chi CS
Acta Paediatr Taiwan; 2000; 41(2):80-4. PubMed ID: 10927944
[TBL] [Abstract][Full Text] [Related]
14. A randomized clinical trial indicates that levamisole increases the time to relapse in children with steroid-sensitive idiopathic nephrotic syndrome.
Gruppen MP; Bouts AH; Jansen-van der Weide MC; Merkus MP; Zurowska A; Maternik M; Massella L; Emma F; Niaudet P; Cornelissen EAM; Schurmans T; Raes A; van de Walle J; van Dyck M; Gulati A; Bagga A; Davin JC;
Kidney Int; 2018 Feb; 93(2):510-518. PubMed ID: 29054532
[TBL] [Abstract][Full Text] [Related]
15. Levamisole treatment in steroid sensitive nephrotic syndrome.
Alshaya HO; Kari JA
Saudi Med J; 2002 Sep; 23(9):1101-4. PubMed ID: 12370722
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of levamisole in children with frequently relapsing and steroid-dependent nephrotic syndrome.
Ekambaram S; Mahalingam V; Nageswaran P; Udani A; Geminiganesan S; Priyadarshini S
Indian Pediatr; 2014 May; 51(5):371-3. PubMed ID: 24953577
[TBL] [Abstract][Full Text] [Related]
17. Clinical efficacy of mycophenolate mofetil versus levamisole therapy in frequently relapsing and steroid dependent childhood nephrotic syndrome - A retrospective comparative analysis.
Sharma S; Kalra S; Shukla S; Sharma P
Nephrology (Carlton); 2022 Sep; 27(9):758-762. PubMed ID: 35619554
[TBL] [Abstract][Full Text] [Related]
18. Levamisole therapy in children with frequently relapsing and steroid-dependent nephrotic syndrome: a single-center experience.
Kuźma-Mroczkowska E; Skrzypczyk P; Pańczyk-Tomaszewska M
Cent Eur J Immunol; 2016; 41(3):243-247. PubMed ID: 27833440
[TBL] [Abstract][Full Text] [Related]
19. Treatment course of steroid-dependent nephrotic syndrome: emphasized on treatment effect.
Chen SY; Wu CY; Tsai IJ; Tsau YK
Nephrology (Carlton); 2010 Apr; 15(3):336-9. PubMed ID: 20470303
[TBL] [Abstract][Full Text] [Related]
20. Short- and long-term efficacy of levamisole as adjunctive therapy in childhood nephrotic syndrome.
Boyer O; Moulder JK; Grandin L; Somers MJ
Pediatr Nephrol; 2008 Apr; 23(4):575-80. PubMed ID: 18204939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
